Long-term outcomes of renal transplantation in patients with HIVAN.

<p>Long-term outcomes of renal transplantation in patients with HIVAN.</p

Mean Serum Creatinine (mg/dl) at 3, 6, 12, 18, and 24 months post-transplant in patients with HIVAN.

<p>Mean Serum Creatinine (mg/dl) at 3, 6, 12, 18, and 24 months post-transplant in patients with HIVAN.</p

Clinical Attributes of all HIVAN renal transplant recipients and their donors.

<p>M, Male; F, Female; AA, African American; C, Caucasian; BMI, Body mass index,? not available; NNRTI, non-nucleoside reverse transcriptase inhibitor; NRTI, nucleoside reverse transcriptase inihibitor; PI, protease inhibitor; INSTI, integrase strand transfer inhibitor; CDCHR, CDC high risk; CIT, Cold ischemia time; Tcr, terminal creatinine; DC, deceased; LR, living related; ATG, anti-thymocyte globulin; CNI, calcineurin inhibitor; MMF, mycophenolate mofetil.</p><p>Clinical Attributes of all HIVAN renal transplant recipients and their donors.</p

Characteristics of patients with HIVAN.

<p>Characteristics of patients with HIVAN.</p

Additional file 1: Figure S1. of Cross-sectional association of volume, blood pressures, and aortic stiffness with left ventricular mass in incident hemodialysis patients: the Predictors of Arrhythmic and Cardiovascular Risk in End-Stage Renal Disease (PACE) study

Boxplot of left ventricular mass index (LVMI) and quartiles of systolic or diastolic blood pressures measured as predialysis 3-month average BP measurement stratified by ethnicity. Figure S2: Boxplot of left ventricular mass index (LVMI) and quartiles of systolic or diastolic blood pressures measured as prior to clinic BP measurement stratified by ethnicity. Figure S3: Boxplot of left ventricular mass index (LVMI) and quartiles of systolic or diastolic blood pressures measured as non-dialysis supine BP measurement stratified by ethnicity. Table S1: Independent associations of predialysis blood pressure, arterial, and volume measures with LVMI by linear regression among incident hemodialysis participants. Table S2: Independent associations of blood pressure prior to study visit, arterial, and volume measures withLVMI by linear regression among incident hemodialysis participants. Table S3: Independent associations of mean arterial pressure, arterial, and volume measures with LVMI by linear regression among incident hemodialysis participants. Table S4: Independent associations of pulse pressures, arterial, and volume measures with LVMI by linear regression among incident hemodialysis participants. Table S5: Association of preload and afterload measures with LVMI by linear regression among incident hemodialysis participants stratified by ethnicity. Table S6: Association of preload and afterload measures with LVMI by linear regression among incidenthemodialysis participants stratified by 3 month average IDWG groups. Table S7: Association of preload and afterload measures with LVMI by linear regression among incident hemodialysis participants stratified by β-blocker medication. Table S8: Association of preload and afterload measures with LVMI by linear regression among incident hemodialysis participants stratified by renin-angiotensin-aldosterone system (RAAS) blockade use. Table S9: Association of preload and afterload measures with LVMI by linear regression among incident hemodialysis participants stratified by history of congestive heart failure. Table S10: Association of hemoglobin with LVMI by linear regression among incident hemodialysis participants. (DOCX 97 kb